Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-19

Clinical Trial Update: Clinical Evaluation of the Pharmacokinetic Goldenseal-Metformin Interaction in Diabetic Patients [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 study evaluated the pharmacokinetic interaction between goldenseal and metformin in adults with Type 2 diabetes; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Goldenseal (Hydrastis canadensis)
  • metformin (metformin)

Snippet

Sponsor: Washington State University | Conditions: Interaction, Adverse Herb-Drug, Diabetes Mellitus, Type 2 | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-12-19